Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac vs Ibuprofen for Sickle Cell Painful Crisis
NCT00115336Phase 4Terminated
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jan 2005
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in sickle cell disease (SCD) comparing Intravenous ketorolac and oral placebo with Intravenous placebo and oral ibuprofen (2 arms). Primary endpoint: Time to a 50% Reduction in Reported Pain Intensity. Started Jan 2005; status: terminated.
02
Drugs
ketorolac
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT00115336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115336.